Related Experiment Videos
A cell line derived from a clinically benign phyllodes tumor: characterization and implications
M A Warso1, R R Mehta, G D Hart
1Department of Surgical Oncology, University of Illinois at Chicago 60612, USA.
Anticancer Research
|March 1, 1995
Summary
Researchers developed new laboratory models for phyllodes tumors, which are rare breast cancers. These cell lines offer a valuable tool for studying phyllodes tumor behavior and developing targeted therapies.
Area of Science:
- Oncology
- Breast Cancer Research
- Tumor Biology
Background:
- Phyllodes tumors are rare breast neoplasms with poorly understood behavior.
- A lack of adequate laboratory models hinders research into phyllodes tumor pathogenesis and treatment.
Observation:
- Two distinct cell lines were successfully established from a benign phyllodes tumor using xenograft and direct cell culture methods.
- These cell lines exhibit consistent characteristics and growth kinetics, forming monolayers of spindle-shaped cells.
Findings:
- Surface marker analysis indicates a mesenchymal origin for the cells.
- The cells lack estrogen and progesterone receptors, suggesting hormone-independent growth.
- Cells demonstrate a rapid doubling time of approximately 1.5 days and show a positive response to insulin stimulation.
- Karyotype analysis revealed the absence of one X chromosome.
Implications:
- These novel cell lines provide crucial in vitro and in vivo models for investigating phyllodes tumor biology.
- The findings pave the way for developing novel therapeutic strategies targeting these rare breast tumors.
- Further research using these models can elucidate the specific molecular mechanisms driving phyllodes tumor progression.